Researchers have defined urinary steroid metabolite levels that indicate inadequate and excessive adrenal suppression for children with congenital adrenal hyperplasia undergoing glucocorticoid treatment.
The randomised Ellipse trial has demonstrated significant blood glucose reductions with the glucagon-like peptide-1 receptor agonist liraglutide in children and adolescents with type 2 diabetes already taking metformin.
Research shows that growth hormone deficiency and central precocious puberty can occur in children several years after traumatic brain injury, even among those with normal pituitary function 1 year after the event.
Researchers advise annual screening for tumours in children with mutations in the SDHB gene, starting from the age of 5 years.
Burosumab treatment improves rickets and prevents decline in growth in young children with X-linked hypophosphataemia, show the findings of an open-label phase II study.
